Zobrazeno 1 - 10
of 134
pro vyhledávání: '"TXNRD1"'
Autor:
Leqi Zhong, Wuguang Chang, Bin Luo, Wuyou Gao, Huanhuan He, Mouxiang Fang, Hongmu Li, Zhesheng Wen, Youfang Chen
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background Disulfidptosis is a recently proposed novel cell death mode in which cells with high SLC7A11 expression induce disulfide stress and cell death in response to glucose deficiency. The purpose of the research was to explore the funct
Externí odkaz:
https://doaj.org/article/542036cc932549898d95e586288b533e
Autor:
Zeyuan Zhong, Chongjing Zhang, Shuo Ni, Miao Ma, Xiaomeng Zhang, Weicong Sang, Tao Lv, Zhi Qian, Chengqing Yi, Baoqing Yu
Publikováno v:
Redox Biology, Vol 63, Iss , Pp 102711- (2023)
Excess osteoclast activity is found in many bone metabolic diseases, and inhibiting osteoclast differentiation has proven to be an effective strategy. Here, we revealed that osteoclast precursors (pre-OCs) were more susceptible to thioredoxin reducta
Externí odkaz:
https://doaj.org/article/d35e076cf5dd4ea8bfbee4b29607e453
Autor:
Jana Samarin, Piotr Fabrowski, Roman Kurilov, Hana Nuskova, Johanna Hummel-Eisenbeiss, Hannelore Pink, Nan Li, Vivienn Weru, Hamed Alborzinia, Umut Yildiz, Laura Grob, Minerva Taubert, Marie Czech, Michael Morgen, Christina Brandstädter, Katja Becker, Lianghao Mao, Ashok Kumar Jayavelu, Angela Goncalves, Ulrike Uhrig, Jeanette Seiler, Yanhong Lyu, Sven Diederichs, Ursula Klingmüller, Martina Muckenthaler, Annette Kopp-Schneider, Aurelio Teleman, Aubry K. Miller, Nikolas Gunkel
Publikováno v:
Redox Biology, Vol 62, Iss , Pp 102639- (2023)
Despite a strong rationale for why cancer cells are susceptible to redox-targeting drugs, such drugs often face tumor resistance or dose-limiting toxicity in preclinical and clinical studies. An important reason is the lack of specific biomarkers to
Externí odkaz:
https://doaj.org/article/43f98fcf2a844645aeeecc65e57523ec
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Externí odkaz:
https://doaj.org/article/77240896446c4a9e8cd8934903eb00ab
Autor:
Yang Yue, Miduo Tan, Yan Luo, Ping Deng, Hui Wang, Jingdian Li, Rongrong Hao, Li Tian, Jia Xie, Mengyan Chen, Zhengping Yu, Zhou Zhou, Huifeng Pi
Publikováno v:
Ecotoxicology and Environmental Safety, Vol 247, Iss , Pp 114270- (2022)
Cadmium (Cd), which is considered an endocrine disruptor, has been linked to the onset of breast cancer (BC). Our recent study demonstrated that Cd-induced BC progression has a strong correlation with miR-374c-5p dysregulation. The aim of our work wa
Externí odkaz:
https://doaj.org/article/af289476985742d3841a973654bacc46
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Liver hepatocellular carcinoma (LIHC) is the major form of liver cancer that is the fourth most common cause of cancer death worldwide. It has been reported that the multifunctional protein p62 (also known as SQSTM1) plays a cancer-promoting role in
Externí odkaz:
https://doaj.org/article/733b6fad8b03446c8dec326c0a68804d
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Idiopathic pulmonary arterial hypertension (IPAH) is a life-threatening cardiopulmonary disease lacking specific diagnostic markers and targeted therapy, and its mechanism of development remains to be elucidated. The present study aimed to explore no
Externí odkaz:
https://doaj.org/article/2a469caeb75e4ce7b5d824fd518c5fe3
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-20 (2020)
Abstract Background Circular RNAs (circRNAs) have been discovered to participate in the carcinogenesis of multiple cancers. However, the role of circRNAs in esophageal squamous cell carcinoma (ESCC) progression is yet to be properly understood. This
Externí odkaz:
https://doaj.org/article/3f0c8706e10f4a92bcac805a07b2d50e